Member Info for badshah13

This is going down as quickly as it rose. Probably someone with a large chunk getting off this one..

Market is crazy, it rise in speculative report and drops on RNS confirmation..

anyone knows what is going on with this sudden spike?

Thats right, Freddie and Valju started this and we can all see the rewards of better management now. Let's hope to get to £3 so that each one can atleast break even. Personally I had averaged down so about 100% rise from here to break even and honestly I had written this one off, so anything here will be bonus.. had about £45k invested in ISA and SIPP together.

Thanks for the link Paddy. On it now

but strangely getting quote for 24p to sell. I think large order to settle in background

Rusty, no disrespect but I hope you can read and understand what I wrote in first place.
If you dont like to see it, there is a filter option

Adamant, that is significant investment. I am new to ORCP following a tip from a friend. Would you mind asking your average buying price?
Also if there any broker note for ORCP?

Loll, well if they had a reason to sell at 22p, they should have better sold off at 24 - 25p a day earlier or stuck around for the reason they invested here even if it was just for GDXJ push on expected Friday. Anyway as I said I am happy to see back of these slopy hands.

Look at GGP trade pattern from the Friday close and the Sp. They also has UT for £33m which drove sp up and everything think that value resembles GDXJ buy at close.

I think yesterday was a blessing in disguise for all the LTH for for couple of reasons below,
1. They got a bargain price if they wished to top up more - i had topped up in morning at 22.5 and I was pleased with the bargain irrespective of what happened for the rest of the day.

2. Traders and volatile holders flushed out meaning that the price should hold better than it would have on Monday. I am hoping it us long term holders left here who are here to see through the MRE. I agree with many posters, those who sold were clueless about GGP prospects.. i only hold about 750k shares , so relative small holding in comparison to many others but here since past 7 years from 0.4p days.

It is common sense if GDXJ are happy to buy at 27p, they are expecting further growth into this and we all knew they news that is in the horizon.
Thanks to Paddy, Hydro and many other posters on this BB because of whom I am so confident about GGP and tree shakes like yesterday are seen as opportunity rather than threat.

there is £91m worth of sell showing up at UT. Not sure if that was GDXJ buy but the price doesn't seem right for the buy.

Its strange this did not shot up at close. GGP shot up from 21.6 to 27p after hours due to GDXJ buy witth £33m, so Mondays open would be 27p.

I was hoping same should have been the case with POG. Or maybe they will deal with this on Monday morning.

BTW added some more at 22.5...! And I am happy with the bargain

this is a tree shake, nothing has changed with the company and lot of news to come. It is MM playing games to filling large GDXJ order.
Good luck to sellers...
Everyone was so positive about this until yesterday and now suddenly the tone has changed.. anyway you can make your own decision

It is mentioned, as below

Sanofi - Ocular assets
In June, the Group announced it had been informed by Sanofi that it intended to return the rights to ophthalmology programmes SAR422459 for Stargardt's disease and SAR421869 for Usher Syndrome type 1b. Once returned the Group will undertake its own internal evaluation to determine the potential future for these programmes and decide whether to commit further resources to them.

This should fly even further today as big seller Beetham, who was selling large chunks in the background is out now..
30p by Friday / Monday looks possible

I said nothing surprising and not I dont like it.
All the information mentioned has been know to us, so nothing surprusing meant no shocks in finances.

Nothing surprising but I like this bit,

"Discussions and feasibility studies are ongoing with various other potential gene and cell therapy partners and the Group aims to increase not only the number of partners but also the number of programmes worked on by existing partners and reconfirms that three new lentiviral vector-based CDMO partnership agreements are expected to be signed during 2020. Additionally, the Group is targeting the spin out / out-licence of one in-house product candidate during 2020 and potential partnership discussions are ongoing, although timings of these transactions are less predictable than those in the CDMO area."

More deals to be expected.

https://www.londonstockexchange.com/news-article/OXB/interim-results/14688741